Proprio
Private Company
Total funding raised: $66M
Overview
Proprio is a private medical technology company pioneering an AI-driven surgical intelligence platform. Its flagship product, Paradigm™, is an FDA-cleared navigation system that uses light-field imaging and computer vision to provide continuous, radiation-free 3D visualization and measurements during surgery, starting with spinal applications. The platform aims to enhance surgical precision, reduce procedure time and radiation exposure, and generate standardized intraoperative data to power system-wide learning and optimization. Proprio's vision extends beyond navigation to building a global surgical data network that compounds insights across procedures and institutions.
Technology Platform
Paradigm™: An AI-driven surgical intelligence platform using light-field imaging, computer vision, and proprietary algorithms for continuous, radiation-free 3D anatomical modeling and real-time measurement during surgery. It generates structured intraoperative data to power a learning system.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Proprio competes in the surgical navigation market dominated by large medtech companies like Medtronic (StealthStation), Stryker (SpineMask, Q Guidance), and Zimmer Biomet (Rosa). Its differentiation is its continuous, radiation-free segmental tracking and its foundational AI model designed to learn from data, positioning it as a next-generation intelligence platform rather than just a navigation tool.